公开(公告)号：US20240228551A9

公开(公告)日：2024-07-11

申请号：US18328162

申请日：2023-06-02

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Maria SCARSELLI ,  Daniele VEGGI

IPC: C07K14/22 ,  A61K39/095 ,  A61P31/04

CPC classification number: C07K14/22 ,  A61K39/095 ,  A61P31/04 ,  C07K2319/00

Abstract: The present invention provides mutated fHbp polypeptides and fusion proteins comprising said mutated fHbp polypeptides that are useful as components of immunogenic compositions for immunizing against Neisseria meningitidis infection.

公开(公告)号：US20210277069A1

公开(公告)日：2021-09-09

申请号：US17265610

申请日：2019-08-09

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Maria SCARSELLI ,  Daniele VEGGI

IPC: C07K14/22 ,  A61K39/095 ,  A61P31/04

Abstract: The present invention provides mutated fHbp polypeptides and fusion proteins comprising said mutated fHbp polypeptides that are useful as components of immunogenic compositions for immunizing against Neisseria meningitidis infection.

公开(公告)号：US20240132550A1

公开(公告)日：2024-04-25

申请号：US18328162

申请日：2023-06-01

Applicant: GLAXOSMITHKLINE BIOLOGICALS SA

Inventor： Maria SCARSELLI ,  Daniele VEGGI

IPC: C07K14/22 ,  A61K39/095 ,  A61P31/04

CPC classification number: C07K14/22 ,  A61K39/095 ,  A61P31/04 ,  C07K2319/00

Abstract: The present invention provides mutated fHbp polypeptides and fusion proteins comprising said mutated fHbp polypeptides that are useful as components of immunogenic compositions for immunizing against Neisseria meningitidis infection.